Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
About Us
 
As an accredited provider of continuing medical education, American Health Resources Inc. is committed to providing pharmacists and other health care professionals with educational development opportunities that are diversified, affordable, and pertinent to their work settings with the objective of improving patient care and outcome.
 


 
 
 
 
 
     
Welcome to American Health Resources
We are pleased to provide you with the following live and distance continuing education opportunities. 
 
Live continuing education conferences are listed below.  Click on the conference title for detailed information and to register.
 
Select the distance tab to view the available home study programs on topics such as:  
 
  • Heart Failure
  • Breast Cancer
  • Medication Errors
  • Skin Cancer
  • E-Prescribing
  • Non-Small Cell Lung Cancer
  • Pharmacy Law
  • Immuno-Oncology
  • Opioid Overdose
  • Chronic Lymphocytic Leukemia 
 
CE Activities Release Date Expiration Date Flyer Hours
Advancements in Therapy for Indolent Non-Hodgkin's Lymphomas 11/21/2016 11/21/2018 N.A. 1.00
Antibiotic Stewardship: Improving Use In The Community 04/20/2017 04/20/2020 N.A. 1.50
Antibiotics in Pregnancy and Lactation 02/23/2016 02/23/2019 N.A. 1.50
Bipolar Disorder Managing the Ups & Downs of a Complex Illness 06/30/2015 06/30/2018 N.A. 1.50
Chronic Insomnia 02/23/2017 02/23/2020 N.A. 1.50
Clinical Advances in Immuno-Oncology 11/09/2016 11/09/2018 N.A. 1.00
Diabetes Update A Focus on SGLT-2 Inhibitors 11/23/2015 11/23/2018 N.A. 1.50
Diabetes Update: The New Concentrated Insulin Products 10/20/2016 10/20/2019 N.A. 1.50
ePrescribing and Its Potential Impact on Medication Error Occurrence 11/09/2015 11/09/2017 N.A. 1.00
Evaluating Biosimilars: A Value Proposition for Health Systems, Hospitals, Practices and Payers (Law) 11/09/2016 11/09/2018 N.A. 1.00
Examining Patient Cases in Pulmonary Arterial Hypertension 07/13/2016 07/13/2019 N.A. 1.25
Fraud, Waste and Abuse Training 10/15/2014 10/15/2017 N.A. 0.50
Heart Failure 10/23/2015 10/23/2018 N.A. 1.50
HIV Infection: An Update on Antiretroviral Therapy – Florida Board-Approved Edition 05/27/2015 05/27/2018 N.A. 2.50
HIV Infection: An Update on Antiretroviral Therapy – Florida Board-Approved Edition for Pharmacy Technicians 05/27/2015 05/27/2018 N.A. 2.50
Hormonal Contraceptives 01/22/2017 01/22/2020 N.A. 1.50
How Will the “Opioid Crisis” Impact the Care of Oncology and Palliative Care Patients 11/22/2016 11/22/2018 N.A. 1.00
Ibs, Mabs and More: Changing the Treatment Landscape for Chronic Lymphocytic Leukemia 11/05/2016 11/05/2018 N.A. 1.00
Immune Based Strategies for Myeloma: Combining Antibodies for Optimal Outcomes 11/29/2016 11/29/2018 N.A. 1.00
Medical Marijuana 12/23/2016 12/23/2019 N.A. 1.50
New Complementary Combination Therapy for Diabetes: Fixed Dose Basal Insulins and GLP-1 Receptor Agonists 01/12/2017 01/12/2019 N.A. 1.25
Omics-Driven Oncology: Challenges Encountered and Lessons Learned 11/10/2016 11/10/2018 N.A. 1.00
Opioid Overdose & Naloxone Rescue Kits 09/20/2015 09/20/2018 N.A. 1.50
Oral Chemotherapy Safety Matters: Designing, Implementing and Assessing an Oral Chemotherapy Management Program 11/22/2016 11/22/2018 N.A. 1.00
Pharmacists & Test Ordering: Roles and Responsibilities 04/23/2015 04/20/2018 N.A. 1.50
The Rapidly Evolving Standard of Care: Focus on the Role, Benefit, and Toxicity of New Therapies in Non-Small Cell Lung Cancer 11/22/2016 11/22/2018 N.A. 1.25
Skin Cancer: Updates and Supportive Care Strategies 11/21/2016 11/21/2018 N.A. 1.00
Sterile Compounding Update: Laws, Regulations & Standards (Law) 11/10/2016 11/10/2018 N.A. 1.25
Cutting Edge Systemic Management of Early Stage Breast Cancer: Current and Future Trials Driving Clinical Practice 11/10/2016 11/10/2018 N.A. 1.00
Travel Health for Pharmacy Technicians 08/23/2015 08/23/2018 N.A. 1.50
Update on the Management of Skin and Soft Tissue Infections in the Era of MRSA 11/20/2014 03/19/2018 N.A. 1.25
Updates on the Treatment of Colorectal Cancer 11/10/2016 11/10/2018 N.A. 1.00